Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 611 is a protein encoded by the ZNF611 gene in humans and is classified as a zinc finger transcription factor. It is predicted to enable sequence-specific DNA binding and regulate transcription by RNA polymerase II, functioning primarily within the cell nucleus. Diseases associated with ZNF611 include certain forms of non-syndromic X-linked intellectual disability. There is no current evidence in major databases or scientific literature that ZNF611 is a direct therapeutic target, no known drug interactions, and it is not currently established as a clinical biomarker or associated with notable safety concerns[1][2][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 611 (ZNF611).